Technical Analysis for HEM - Hemostemix Inc.

Grade Last Price % Change Price Change
C 0.085 6.25% 0.005
HEM closed up 6.25 percent on Wednesday, November 20, 2024, on 73 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 27
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Doji - Bullish? Reversal 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 6.25%
BB Squeeze Ended Range Expansion 6.25%

   Recent Intraday Alerts

Alert Time
Bearish 180 Entry 3 days ago
Fell Below Previous Day's Low 3 days ago
Down 5% 3 days ago
Down 3% 3 days ago
Down 2% 3 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Hemostemix Inc is a Canada-based clinical-stage biotechnology company. The Company's principal business is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions, including critical limb ischemia (CLI). The Company's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of CLI. ACP-01 is in a Phase II clinical trial in Canada, South Africa and the United States. The Company also focuses on developing other cell products, such as bone cell precursors (BCPs), myocardial cell precursors (MCPs) and neural cell precursors (NCPs). It operates in Canada and Israel. The Company has approximately 2,200 square foot research and manufacturing facility in Ness Ziona, Israel. Hemostemix Limited is the subsidiary of the Company.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Nature Clinic Biotechnology Therapy Biology Clinical Trial Bone Hypertension Cell Biology Stem Cells Cell Products Cell Therapy Manufacturing Facility

Is HEM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.12
52 Week Low 0.035
Average Volume 183,913
200-Day Moving Average 0.067
50-Day Moving Average 0.087
20-Day Moving Average 0.094
10-Day Moving Average 0.089
Average True Range 0.010
RSI (14) 47.92
ADX 15.62
+DI 23.886
-DI 27.100
Chandelier Exit (Long, 3 ATRs) 0.081
Chandelier Exit (Short, 3 ATRs) 0.109
Upper Bollinger Bands 0.111
Lower Bollinger Band 0.077
Percent B (%b) 0.24
BandWidth 36.247
MACD Line 0.001
MACD Signal Line 0.003
MACD Histogram -0.0018
Fundamentals Value
Market Cap 65.89 Million
Num Shares 775 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -4.05
Price-to-Sales 0.00
Price-to-Book 27.76
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.093
Resistance 3 (R3) 0.092 0.088 0.091
Resistance 2 (R2) 0.088 0.086 0.089 0.091
Resistance 1 (R1) 0.087 0.085 0.088 0.088 0.090
Pivot Point 0.083 0.083 0.084 0.084 0.083
Support 1 (S1) 0.082 0.081 0.083 0.083 0.080
Support 2 (S2) 0.078 0.080 0.079 0.079
Support 3 (S3) 0.077 0.078 0.079
Support 4 (S4) 0.078